The US FDA & Brigham and Women's Hospital/Harvard Medical School to use Aetion's software platform to re-create RCTs through RWE

Source :: M2 Pharma. May 9, 2018
Publication Year :: 2018
Abstract: M2 PHARMA-May 9, 2018-The US FDA & Brigham and Women's Hospital/Harvard Medical School to use Aetion's software platform to re-create RCTs through RWE (C)2018 M2 COMMUNICATIONS Health care technology company [...]

Subjects :: United States. Food and Drug Administration -- Technology application
Software industry -- Technology application
Drug approval -- Technology application
Medical schools -- Technology application
Technology application
Chemistry
Harvard University. Harvard Medical School -- Technology application

Tools